Krenning E - Search Results

1

New advances in peptide receptor radionuclide therapy.

de Jong M, Krenning E. de Jong M, et al. Among authors: krenning e. J Nucl Med. 2002 May;43(5):617-20. J Nucl Med. 2002. PMID: 11994523 Free article. No abstract available.

2

111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.

Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M. Capello A, et al. Among authors: krenning e. Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1288-95. doi: 10.1007/s00259-005-1877-x. Epub 2005 Jul 15. Eur J Nucl Med Mol Imaging. 2005. PMID: 16021448

3

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

de Jong M, Barone R, Krenning E, Bernard B, Melis M, Visser T, Gekle M, Willnow TE, Walrand S, Jamar F, Pauwels S. de Jong M, et al. Among authors: krenning e. J Nucl Med. 2005 Oct;46(10):1696-700. J Nucl Med. 2005. PMID: 16204720 Free article.

4

Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.

Konijnenberg M, Melis M, Valkema R, Krenning E, de Jong M. Konijnenberg M, et al. Among authors: krenning e. J Nucl Med. 2007 Jan;48(1):134-42. J Nucl Med. 2007. PMID: 17204710 Free article.

5

Peptide-receptor radionuclide therapy for endocrine tumors.

van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ. van Essen M, et al. Nat Rev Endocrinol. 2009 Jul;5(7):382-93. doi: 10.1038/nrendo.2009.105. Epub 2009 Jun 2. Nat Rev Endocrinol. 2009. PMID: 19488074 Review.

6

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Rolleman EJ, Melis M, Valkema R, Boerman OC, Krenning EP, de Jong M. Rolleman EJ, et al. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1018-31. doi: 10.1007/s00259-009-1282-y. Epub 2009 Nov 14. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915842 Review.

7

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP. Kwekkeboom DJ, et al. Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19995807 Review.

8

Preclinical and clinical studies of peptide receptor radionuclide therapy.

Pool SE, Krenning EP, Koning GA, van Eijck CH, Teunissen JJ, Kam B, Valkema R, Kwekkeboom DJ, de Jong M. Pool SE, et al. Among authors: krenning ep. Semin Nucl Med. 2010 May;40(3):209-18. doi: 10.1053/j.semnuclmed.2009.12.001. Semin Nucl Med. 2010. PMID: 20350630 Review.

9

Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides.

Melis M, Vegt E, Konijnenberg MW, de Visser M, Bijster M, Vermeij M, Krenning EP, Boerman OC, de Jong M. Melis M, et al. Among authors: krenning ep. J Nucl Med. 2010 Jun;51(6):973-7. doi: 10.2967/jnumed.109.074310. Epub 2010 May 19. J Nucl Med. 2010. PMID: 20484435 Free article.

10

Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.

Melis M, de Swart J, de Visser M, Berndsen SC, Koelewijn S, Valkema R, Boerman OC, Krenning EP, de Jong M. Melis M, et al. J Nucl Med. 2010 Dec;51(12):1962-8. doi: 10.2967/jnumed.110.080143. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078795 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters